Microarray is an advanced molecular biology technique used to spot expressions of many genes at the same time. Gene expression is a crucial part of normal gene functioning and plays significant role in understanding normal growth and development of life. Any abnormalities in gene functioning can lead to critical disease. Research involving the study of many genes by traditional method is next to impossible. Microarrays serve the purpose. Thousands of genes can be arrayed at one time and analyzed accurately. It is fast, accurate, cost effective and easy to do assay design. Microarray can be used for many micro molecules such as DNA, RNA, proteins, and also for enzymes, carbohydrates, and tissues. It can be used for gene expression profiling, molecular interactions, biomarker profiling, enzyme activity, pathway identification, and mutations. Microarray is not limited to basic research, but has expanded to clinical research and diagnosis.
Based on type, microarrays can be segmented into DNA microarrays, protein microarrays, and antibody microarrays. DNA microarrays can be used for single nucleotide polymorphism-based diagnostics, forensic detection, gene expression profiling, etc. Large number of applications of DNA microarrays makes it a major segment of the microarray market. Protein microarrays are used in biomarker screening, enzyme substrate profiling, small molecule profiling, protein-protein interaction, etc. Antibody microarrays find applications in immunology in antibody specificity profiling, electronic immunoassays, etc.
In terms of application, microarrays can be segmented into gene expression profiling tool, comparative genomics tool, disease diagnosis, drug discovery, and toxicological research involving the uncharacterized microbial populations exposed to toxins and pollutants. With the help of microarrays some of the uncharacterized microbes can be identified and their original gene pattern and functionality can be studied. Microarray technology has provided a new insight into the evolutionary studies, as many arrays can be studied parallel that are specific for particular species. Microarrays can be used in comparative genomics and pathway probing. Microarrays provide information, though not complete but useful, about the gene or group of genes that can be studied further, illuminating the biological pathways. Microarray has helped in better understanding of some diseases, their pathogenesis, and genetics. Scientists are able to differentiate cancer on the basis of organs harboring tumor, leading to a better understanding of gene pattern in the tumor cells. Microarray has also benefitted therapeutics development. Better understanding of any drug addiction followed by better treatment in any patient is an example of it. In diagnosis of diseases, particularly at the time of outbreaks, where a quick and accurate diagnosis is required, microarray has gained recognition in identifying the causative agent or the pathogen and the specific strain or antigen (serotype).
Based on product type and analysis, the microarray market can be segmented into consumables and instruments. Large number of applications of microarray has led to high demand for consumables such as reagents, primers, buffers, DNA chips, and reagent kits.
Microarray has widespread applications in genomics as well as proteomics. The progressively evolving information and software technology and emerging bioinformatics are some of the factors driving the microarray market, making it economical, unfailing, and durable. The development of biological products such as vaccines and therapeutic proteins involving microarray technologies could lead to promising results. However government protocols have mentioned that minor changes in the biological process may lead to distinguished end product, there is an urgent need of extensive testing and authentication. And these factors may hamper the market.
In terms of region, the microarray market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest market for microarrays. Advanced technology, high quality result oriented research, public awareness about personal health, and government initiatives are the factors contributing to the growth of the microarray market in North America. Europe was the second largest market for microarrays, followed by Asia Pacific. Increasing awareness among the people about genetic diseases, education, government initiatives, and modern technology in diagnosis and treatment of diseases are propelling the microarray market in Asia Pacific.
Key players in the microarray market are Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific and Merck. Other companies include Applied Microarrays, BioGenex, Perkin Elmer, QIAGEN, and Phalanx Biotech.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.